Arcticzymes Technologies ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Arcticzymes Technologies ASA with three other
pharmaceutical manufacturers in Europe:
sales of 8.90 million Euros [US$10.83 million]
Diurnal Group PLC
of UNITED KINGDOM
(£6.31 million [US$8.93 million]
of which 100%
was Development and Supply), and
Enzymatica AB (publ)
based in SWEDEN
(111.25 million Swedish Kronor [US$13.44 million]
During the year ended December of 2020, sales at
Arcticzymes Technologies ASA were NOK 93.45 million (US$11.15 million).
increase of 21.0%
versus 2019, when the company's sales were NOK 77.25 million.
This was the third consecutive year of growth at Arcticzymes Technologies ASA.